Mutations in the DNA-binding or transactivation domain of STAT3 in hyper-IgE syndrome patients are known to negatively impact immune cell function and exacerbate infectious disease and EBV lymphomas (60, –, 64). Here, STAT3 is linked to hyper-IgE syndrome.